Manliquez, Clouie L.
HRN: 28-09-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2026
CEFUROXIME 750MG (VIAL)
06/09/2026
06/16/2026
IV
240mg
Q8hours
Urinary Tract Infection
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: